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Intestinal damage as a result of allergy and infection is a major cause of mor-
bidity in man and animals (1-3) . In intestinal allergy the most commonly seen
lesions are small intestinal villous atrophy and crypt cell hyperplasia resulting in
malabsorption due to a decreased intestinal absorptive surface and decreased
digestive enzyme levels in the epithelial cells. The mechanisms involved in these
changes in man are not known, but there is evidence from experimental animal
studies that T cells may play an important role in the pathogenesis of the intes-
tinal lesion (4). The enteropathy observed in intestinal graft-versus-host disease
and rejection of transplanted intestinal allografts is characterized by a lympho-
cytic infiltrate, shortening of the villi, lengtheningof the crypts and an increased
rate of epithelial cell proliferation (5, 6) . However, these in vivo models,
although useful, do not allow a dissection of the mechanisms involved in the
development of enteropathy in human small intestine .
We have recently shown (7) that fetal human small intestine becomes increas-
ingly populated with T cells from ^-14 wk of gestation . By 19-22 wk the fetal
gut epithelium and lamina propria contain many isolated T cells and the lamina
propria contains aggregates of T and B cells that are probably early Peyer's
patches (8). Small explants of human fetal small intestine can be maintained in
organ culture for several weeks with retention of gut structure and normal epi-
thelial cell function (9) . We have thus attempted to directly stimulate mucosal T
cells in situ in cultures of human small intestine.
Materials and Methods
Organ Culture of Fetal Human Small Intestine.
￿
Small intestine from therapeutically
aborted fetuses was placed in a petri dish in serum-free CMRL-1066 medium (Flow Lab-
oratories, Inc ., McLean, VA) modified as described by Autrup et al (10) . The intestine
was cut into segments 2-3 mm in length which were then bisected longitudinally to
expose the lumen . The explants were then trimmed into pieces 2-3 mm square . Five
pieces of tissue were cultured in 7 ml modified CMRL-1066 medium in 5-cm diameter
tissue culture dishes (Sterilin ; Scientific Supplies Co . Ltd ., Vine Hill, London) . The cul-
tures were incubated for 72 h at 37°C in a 95% oxygen, 5% CO atmosphere . At the end
of the culture period the five explants in each dish were carefully removed from the
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culture dish and placed on top of one another on a piece of filter paper to absorb excess
moisture. The tissues were then snap frozen in liquid nitrogen and stored at -70°C.
Frozen sections profiling each of the explants were then cut and stained immunohisto-
chemically using the peroxidase technique as described elsewhere (11). mAbs used for
immunohistochemistry were Ki67 (Dako Ltd., High Wycombe, Bucks) which identifies a
nuclear antigen in all dividing cells and the anti-T cell antibodies anti-CD3 (Leu-4), CD4
(Leu-3a), CD8 (Leu-2a), and CD25 (anti-Tac) purchased from Becton Dickinson & Co.,
Mountain View, CA.
Activation ofMucosal T Cells In Situ in Explants of Fetal Small Intestine.
￿
Two methods
were used. First, PWM (Flow Laboratories, Inc.) was added to the cultures at a concen-
tration of 15 kg/ml, a concentration shown to be optimal in preliminary experiments.
Second, anti-CD3 mAb (Serotec Ltd., Kiddington, Oxford) was added to the cultures.
Measurement of CD25+ Cells in the Lamina Propria of Explants of Fetal Small Intes-
tine. Frozen sections of explants of fetal gut were stained immunohistochemically with
monoclonal anti-CD25. The number of lamina propria cells staining with this antibody
was quantitated by counting the number of stained cells in random fields using the X40
objective on a Leitz Dialux microscope. At least 10 fields per group were counted.
IL-2 Activity in the Organ Culture Supernatants.
￿
IL-2 activity was assayed by a standard
method using CTLL-16 cells (12). Briefly, 100 ul of supernatant was diluted twofold in
RPMI 1640 with 10% FCS. To each well was added 4,000 CTLL-16 cells. The next day
the cells were pulsed with 1 pCi ['H]thymidine and the wells were harvested for liquid
scintillation counting 8 h later. Each culture supernatant was measured in duplicate with
identical results.
Measurement of Crypt Epithelial Cell Division and Villous Height.
￿
Crypt epithelial cell
division was measured by counting the number of nuclei staining immunohistochemically
with the mAb Ki67+ per crypt in well-oriented sections. Ki67 detects an epitope present
on the nuclei of all dividing human cells. The nuclei of cells in Go do not stain. At least
10 measurements were made per group. Because the frozen sections of the aggregates
of five explants were frequently poorly oriented, all measurements of villous height were
done blind. Sections were coded and the heights of the villi that appeared to be sectioned
through their length were measured using a calibrated micrometer eyepiece. At least 10
measurements of villous height per group were made.
Statistics. All results are expressed as the mean ± 1 SE. All measurements in any
group were first tested to determine if they conformed to a sample from a normally
distributed population. If so, differences between groups was determined using analysis
of variance. If the values in a group were not normally distributed then groups were
compared using the nonparametric Kolmogorov-Smirnov two-group test. All statistics
were done using a Microstat statistical program on an Amstrad PC1512 microcomputer.
Results
In Situ Lectin-induced T Cell Activation in the Mucosa ofFetal Human Small Intes-
tine In Vitro. Fetal small intestine from 12 fetuses ranging in age from 14-22
wk gestation was cultured in vitro with PWM (15pg/ml) for 3 d and then exam-
ined for the presence of CD25+ cells by immunohistochemistry (Table I) . There
were few CD25 + cells in the lamina propria of PWM-treated cultures of 14-17-
wk-old fetal intestine, but in the specimens aged 18-22 wk these were abundant
in the lamina propria. There were no CD25 + cells in control cultures. IL-2 levels
in the organ culture supernatants were also measured (representative experi-
ments shown in Fig. 1) . Although the levels of activity detected were small, the
amount of IL-2 produced after PWM-stimulation also increased with fetal age.
The majority of the cells in the lamina propria of the PWM-stimulated cul-
tures were CD8 -. There were numerous CD4+ cells but it was difficult to deter-
mine if they were T cells or macrophages since Leu-3a is present on tissue mac-750-
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250-
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TABLE I
The Number ofCD25 + Cells in the Lamina Propria of Fetal Small
Intestinal Organ Cultures of Various Ages after Treatment with PWM
There were no CD25+ cells in the lamina propria of any of the control
organ cultures. All measurements were made after 3 d in culture with
PWM (15 Ag/ml). CD25+ (anti-Tac) cells in the lamina propria were enu-
meratedby counting the number of cells staining immunohistochemically
with monoclonal anti-CD25 (Becton Dickinson & Co.) in random X 40
fields. At least 10 fields per explant were counted. Preliminary experi-
ments showed that 15 Wg/ml was the optimal dose of PWM and that the
numbers of CD25+ cells in the lamina propria reached peak levels on
day 3.
rophages (13). There was no evidence of B cell activation in any of the
specimens.
Changes in Mucosal Morphology and Epithelial Cell Proliferation Associated with T
Cell Activation. Profound morphologic changes in the explants of small intes-
tine were also seen after the addition of PWM, especially in the 18-22-wk-old
tissues. These were best highlighted immunchistochemically using Ki67 to detect
dividing cells (Fig 2). Whereas in control cultures there were few epithelial cells
in division in the crypts of Lieberkuhn, after the addition of PWM there was a
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FIGURE: 1 .
￿
IL-2 activity in the culture supernatants of explants (five/dish) of fetal small
intestine of differentages. (-; .--) Cultures stimulated with 15 bg/ml PWM, (-"-) control
cultures. All supernatants were harvested after 2-3 d of culture. CTLL-16 cells cultured in
medium alone gave 100-200 cpm. In a 1:2 dilution of MLA-144 supernatant used as a stan-
dard, the CTLL-16 gave 20,000 cpm.
Ageof specimen Exp. CD25 + cells/X 40 field
wk
14 1 0
16 1 0
2 2.3 ± 1.3
3 2.1 ± 0.9
4 7.5 ± 1.8
17 1 2.3 ± 0.9
18 1 4.0 ± 0.9
2 12.5 ± 1.5
20 1 15.9 ± 4.4
21 1 11.2 ± 2.3
2 19.4 ± 2.5
22 1 21 .3 ± 2.61344
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FIGURE 2 .
￿
The morphologic changes produced by the addition ofPWM to in vitro cultures
of explants of 18-wk-old fetal small intestine (immunoperoxidase, X 40) . Shown are frozen
sections of fetal gut cultured for 72 h in medium alone (A) or 15 Aglml PWM (B) . The
sections were stained immunohistochemically with the mAb Ki67 (Dako Ltd.), which stains
the nuclei of dividing cells, to highlight the increase in the number ofdividing crypt epithelial
cells (arrows). In control cultures, the villi are long and the crypts are short, with few Ki67+
cells . In contrast, in cultures to which PWM has been added there is almost total villous
atrophyand intense epithelial cell proliferation in the crypts . The oedema in the villous core
of the control cultures is due to water absorption by the villous epithelial cells that accumu-
lates in the villi because there is no lymphatic or venous drainage .80
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FIGURE 3. (A) The time course of the
changes in the number of dividing cells in the
crypts of Lieberkuhn induced by PWM (15
wg/ml) in cultures of 21-wk-old fetal small
intestine. The number of dividing cells was
estimatedby counting thenumber of epithelial
cell nuclei staining immunchistochemically
with Ki67 in frozen sections of well-oriented
crypts. At least 10 crypts/group were counted.
At each time point the increase in the number
of Ki67' cells compared with control cultures
was significant (day 1, p < 0.03; day 5, p <
0.001; day 3, p < 0.000001; day 7, p <
0.000001). (B) The development of villous
atrophy in explants of 21-wk-old fetal human
small intestine stimulated with PWM (15 wg/
ml). In control and PWM-treated cultures
there was a decrease (p < 0.001) in villous
height on day 1 compared with the onset of
culture, however at days 3 and 5 and 7 there
was a dramatic villous atrophy in the PWM-
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AGE OF FETAL GUT (WEEKS)
￿
villous height did not change from day 1. The
decrease on days 3-7 was highly significant (p
< 0.000001 in all cases), The decrease in villous height in control cultures over the first 24 h is
almost certainly a result of the villous core swelling with water actively transported across the epi-
thelial cells from the culture medium. (C) The relationship between the age of the fetal intestine
and the degree of crypt cell hyperplasia induced by PWM (15 Ag/ml in all cases). All specimens
were examined after 3 d of culture. Two 14-wk-old fetuses were studied, only one of which did the
PWM induce an increase in Ki67 + cells (p < 0.05). In all the older specimens studied the PWM
induced a significant increase in Ki67+ cells (16 wk, p < 0.05; both 18-wk-old specimens, p <
0.002; 20 wk, p < 0.003 ; 21 wk, p < 0.008).
dramatic crypt cell hyperplasia which peaked at 3 d but was still evident after 1
wk in culture (Fig. 3 A) . The crypt hyperplasia was also associated with villous
atrophy (Fig 3 B). It was also clear that the extent of the crypt hyperplasia
increased with the age of the tissue (Fig. 3 Q.1346 T CELLS IN THE PATHOGENESIS OF ENTEROPATHY
TABLE 11
Cyclosporin A Inhibits the Development ofCrypt Epithelial Cell Hyperplasia and
the Appearance ofCD25' cells in PWM-treated Organ Cultures ofFetal Human
Small Intestine
Each group contained five fetal small intestinal explants. The tissue was snap frozen on
day 3 of culture and the number of dividing cells in the crypts measured in frozen sec-
tions as described in Fig 3. CD25 + (anti-Tac) cells in the lamina propriawere enumer-
ated by counting the number of cells staining immunohistochemically with monoclonal
anti-CD25 (Becton Dickinson & Co.) in random X 40 fields. At least 10 fields per
explant were counted. The PWM and Cyclosporin A were added at the onset of the
culture. Cyclosporin A (Sandoz) wasdiluted in culture medium to the appropriate con-
centration. In each experiment the increase in the number of Ki67+ cells/crypt induced
by PWM was significant (p < 0.001 for the 20-wk-old gut, p < 0.0002 for the 16-wk-
old gut), as was the reduction produced by the addition of the Cyclosporin A (p <
0.001, for the 20-wk-old gut, p < 0.004 for the 16-wk-old gut) . Similarly the reduction
in the number of CD25+ cells was significant (p < 0.05, for the 16-wk-old gut, p <
0.002 for the 20-wk-old gut).
Cyclosporin A Inhibits the Development of Crypt Cell Hyperplasia in PWM-treated
Fetal Small Intestine. To help exclude the possibility that the changes observed
were due to the direct effect of PWM on the epithelial cells we added Cyclos-
porin A (Table 11), a potent inhibitor of T cell activation (14, 15), to some of
the PWM-stimulated cultures. The addition of 15 jug/ml Cyclosporin A at the
onset of culture almost completely prevented the development of CD25+ cells
in the lamina propria and crypt epithelial cell hyperplasia.
T Cell Activation with Anti-CD3 Antibody Results in Crypt Epithelial Cell Hyper-
plasia. Explants of fetal intestine were also treated with anti-CD3 antibody to
directly activate mucosal T cells. This resulted in the appearance of CD25+ cells
in the lamina propria of the explants (not shown) and a dose-dependent increase
in the number of dividing crypt epithelial cells (Table 111) .
Discussion
These studies indicate that activation of mucosal T cells in human small intes-
tine in vitro rapidly produces crypt epithelial cell hyperplasia and villous atro-
phy. The degree of mucosal lymphocyte activation was related to the age of the
tissue studied. Noticeably, PWM had virtually no effect on 14-wk-old fetal intes-
tine, which has few T cells, as shown previously (7, 8). As the age of the speci-
mens tested increased and the mucosa contained more T cells at the onset of
culture so the PWM induced more CD25+ cells in the lamina propria and the
greater the mucosal changes. Cyclosporin A also inhibited both the development
of CD25+ cells and tissue damage after the addition of PWM. Finally, anti-CD3
Exp. 1 (l6-wk-old gut) Exp. 2 (20-wk-old gut)
Ki67+ cells
percrypt
CD25+ cells
per field
Ki67+ cells
percrypt
CD25+ cells
per field
Control 0.7 ± 0.3 0 0.4 ± 0.2 0
PWM (15Ag/ml) 12.0±3.7 7.5±1 .8 35.2±2.7 15.8±4.4
Cyclosporin A (15 ag/ml) 0.7 ± 0.5 0 1.6 ± 0.6 0
PWM .t CycloA 2.3 ± 0.9 0.3 ± 0.2 1.0 ± 0.5 2.2 ± 0.5MACDONALD AND SPENCER
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TABLE III
Activation of Mucosal T Cells with Anti-CD3 Antibody Results in
Dose-dependent Crypt Epithelial Cell Nyperplasia
Explants from a 17-wk-old fetus were cultured in anti-(:I)3 at the indicated
concentrations. 3 d later the tissues were snap frozen and stained hnmu-
nohistochemically with Ki67. The increase in Ki67 cells/crypt induced by
0.5 and 2.5 ug/ml anti-CD3 were highly significant (P < 0.0001).
antibody-induced mucosal T cell activation also resulted in a dose-dependent
crypt hyperplasia. Taken together, these results provide compelling evidence
that a consequence of mucosal T cell activation is crypt epithelial cell hyperplasia
and villous atrophy. We consider it unlikely that the PWM-induced effects arc
due to direct effects on epithelial cells for two reasons. First, in preliminary elec-
tron microscopy studies we are unable to demonstrate epithelial cell damage
after the addition of PWM. Second, biotin-labeled PWM binds to the epithelial
cells of 14-wk-old fetal intestine to the same extent as in older tissues (not
shown), thus making it unlikely that the failure of the PWM to induce changes
in intestine of this age is due to the absence of PWM receptors.
In this model we used a polyclonal activator or anti-CD3 antibody to stimulate
mucosal T cells, but we would envisage that clinical enteropathy occurs when
sensitized small intestinal lymphocytes interact with nominal antigen from the
gut lumen, such as gluten in the case of celiac disease. One of the advantages
of working with sterile explants of fetal small intestine in vitro is that the inter-
pretation of the results is not confused by multiple immunologic events. For
example, in the case of a celiac patient challenged with gluten, the patient will
almost certainly have high levels of antibody to gluten (16), capable of causing
immune complex deposition in the mucosa (17).
The mechanisms by which T cells mediate the enteropathy described here are
unknown. The most striking feature to us was the rapid and profound increase
in the rate of crypt epithelial division, which may suggest a direct effect of the
activated T cells or their products on these cells. PWM induces at least a subset
of the lamina propria T cells to secrete lymphokines since we were able to detect
IL-2 and IFN-'Y (data not shown) in the supernatants of the damaged explants.
However, these lymphokines on their own are not responsible for the mucosal
changes, since we have tested both recombinant lymphokines at a variety of
doses and they have little effect on mucosal morphology (negative data, not
shown) . Rather, the presence of IL-2 in the organ culture supernatant was only
used to show that PWM treatment resulted in functional T cell activation. Fur-
ther investigation is necessary to determine if any known (or perhaps new) lym-
Concentration of
anti-CD3 antibody
Ki67+ cells percrypt
mean ± 1 SE
,ug/ml
- 3.7 ± 1 .4
0 .1 8.0 ± 2.2
0.5 15.0 ± 2.3
2 .5 20.2 ± 2.51348
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phokine(s) are capable of influencing the rate of epithelial cell renewal, either
directly or via interaction with mesenchymal cells in the lamina propria.
Summary
T cells in explants of human fetal small intestine in organ culture were stim-
ulated in situ with PWM or anti-CD3 antibody to test the hypothesis that acti-
vated T cells produce enteropathy in human small intestine. T cell activation was
measured by the appearance of CD25 + cells in the lamina propria of the
explants and IL-2 production into the organ culture supernatant. We have pre-
viously shown (7, 8) that the number of T cells in human fetal gut increased
between 14 and 22 wk gestation. Accordingly, after the addition of PWM to
cultured explants of fetal intestine the number of CD25 + cells in the lamina
propria and the amounts of IL-2 secreted into the organ culture supernatant
increased with the age of the explanted tissue . The addition of PWM also pro-
duced an age-related enteropathy, most noticeably crypt epithelial cell hyperpla-
sia and villous atrophy, with relatively minor changes in 14-17-wk-old intestine
but severe tissue damage in 18-22-wk-old fetal intestine. These enteropathic
effects were also produced when mucosal T cells were activated with anti-CD3
mAb. Cyclosporin A completely inhibited the PWM-induced development of
CD25 + cells and related tissue damage. These experiments show that activated
T cells in human small intestine produce enteropathy. The model provides a new
system with which to dissect the mechanisms of T cell-mediated intestinal
damage.
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